Logos Global Management LP Century Therapeutics, Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.57 - $13.1 $141,267 - $215,940	-16,484 Reduced 3.46%	460,075 $4.55 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $12.43 $586,652 - $916,091	-73,700 Reduced 13.39%	476,559 $4 Million
Q1 2022 May 16, 2022	SELL	$11.62 - $15.92 $741,774 - $1.02 Million	-63,836 Reduced 10.4%	550,259 $6.93 Million
Q4 2021 Feb 14, 2022	SELL	$13.93 - $23.62 $348,250 - $590,500	-25,000 Reduced 3.91%	614,095 $9.74 Million
Q3 2021 Nov 15, 2021	SELL	$20.8 - $31.93 $7.28 Million - $11.2 Million	-350,000 Reduced 35.39%	639,095 $16.1 Million
Q2 2021 Aug 16, 2021	BUY	$22.45 - $29.34 $22.2 Million - $29 Million	989,095 New	989,095 $29 Million

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $61.8M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.